BUSINESS

Analyst bullish on Stoke Therapeutics stock following key epilepsy drug data

Moderator - Tomas KauerModerator - Tomas Kauer
Sep 11, 2024 - 14:00
Analyst bullish on Stoke Therapeutics stock following key epilepsy drug data
Read More

Tags:

Previous Article

SciSparc extends $1.85 million loan to Automax

Next Article

CAVA Group stock target raised by Argus on growth opportunities

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Moderator - Tomas Kauer
Moderator - Tomas Kauer

Related Posts

Elastic founder on returning to open source four years after going proprietary

Elastic founder on returning to open source four years ...

Moderator - Tomas... Sep 29, 2024

Here’s how Apple is making iPhone 16 more repairable

Here’s how Apple is making iPhone 16 more repairable

Moderator - Tomas... Sep 18, 2024

Ollie scoops up health startup to launch a tool that analyzes dog poop

Ollie scoops up health startup to launch a tool that an...

Moderator - Tomas... Oct 3, 2024